The Procter & Gamble Company (NYSE:PG) Shares Bought by Fiduciary Group LLC

Fiduciary Group LLC raised its position in The Procter & Gamble Company (NYSE:PGGet Rating) by 7.7% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 45,228 shares of the company’s stock after acquiring an additional 3,234 shares during the quarter. Fiduciary Group LLC’s holdings in Procter & Gamble were worth $6,570,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. CFS Investment Advisory Services LLC boosted its position in shares of Procter & Gamble by 15,150.1% during the 1st quarter. CFS Investment Advisory Services LLC now owns 4,075,289 shares of the company’s stock worth $642,000 after purchasing an additional 4,048,566 shares in the last quarter. Boston Partners lifted its holdings in Procter & Gamble by 14,217.6% in the 1st quarter. Boston Partners now owns 3,415,888 shares of the company’s stock valued at $522,695,000 after purchasing an additional 3,392,030 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Procter & Gamble by 1.1% during the 1st quarter. Vanguard Group Inc. now owns 217,519,281 shares of the company’s stock valued at $33,236,946,000 after acquiring an additional 2,394,234 shares during the last quarter. GQG Partners LLC increased its stake in shares of Procter & Gamble by 31.7% during the 1st quarter. GQG Partners LLC now owns 9,918,574 shares of the company’s stock valued at $1,515,166,000 after acquiring an additional 2,386,691 shares during the last quarter. Finally, Bridgewater Associates LP increased its stake in shares of Procter & Gamble by 31.5% during the 1st quarter. Bridgewater Associates LP now owns 6,823,611 shares of the company’s stock valued at $1,042,648,000 after acquiring an additional 1,634,471 shares during the last quarter. 63.45% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

PG has been the subject of a number of research analyst reports. UBS Group dropped their price objective on shares of Procter & Gamble from $153.00 to $135.00 in a research note on Thursday, October 13th. Wells Fargo & Company increased their target price on shares of Procter & Gamble from $150.00 to $155.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 16th. Evercore ISI dropped their target price on shares of Procter & Gamble to $145.00 in a research report on Thursday, October 20th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Procter & Gamble from $155.00 to $156.00 and gave the stock a “buy” rating in a research report on Thursday, October 20th. Finally, Barclays upped their price target on Procter & Gamble from $139.00 to $145.00 and gave the stock an “overweight” rating in a report on Thursday, October 20th. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $151.00.

Procter & Gamble Stock Performance

Shares of PG traded up $0.83 during trading hours on Thursday, reaching $146.45. 4,296,014 shares of the company’s stock traded hands, compared to its average volume of 6,557,472. The firm has a market capitalization of $349.36 billion, a price-to-earnings ratio of 25.38, a P/E/G ratio of 4.18 and a beta of 0.41. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.62 and a quick ratio of 0.41. The Procter & Gamble Company has a twelve month low of $122.18 and a twelve month high of $165.35. The business’s fifty day simple moving average is $133.59 and its two-hundred day simple moving average is $140.37.

Procter & Gamble (NYSE:PGGet Rating) last issued its quarterly earnings results on Wednesday, October 19th. The company reported $1.57 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.02. The company had revenue of $20.61 billion for the quarter, compared to analyst estimates of $20.37 billion. Procter & Gamble had a return on equity of 32.66% and a net margin of 18.11%. The company’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same period last year, the company earned $1.61 earnings per share. Analysts predict that The Procter & Gamble Company will post 5.83 earnings per share for the current year.

Procter & Gamble Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 15th. Stockholders of record on Friday, October 21st were paid a dividend of $0.9133 per share. The ex-dividend date of this dividend was Thursday, October 20th. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.91. This represents a $3.65 dividend on an annualized basis and a dividend yield of 2.49%. Procter & Gamble’s dividend payout ratio (DPR) is 63.26%.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, CEO R. Alexandra Keith sold 33,968 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, November 8th. The stock was sold at an average price of $137.44, for a total value of $4,668,561.92. Following the transaction, the chief executive officer now directly owns 38,990 shares of the company’s stock, valued at approximately $5,358,785.60. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In related news, CEO R. Alexandra Keith sold 33,968 shares of the business’s stock in a transaction on Tuesday, November 8th. The stock was sold at an average price of $137.44, for a total value of $4,668,561.92. Following the sale, the chief executive officer now owns 38,990 shares of the company’s stock, valued at approximately $5,358,785.60. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Sundar G. Raman sold 14,922 shares of the business’s stock in a transaction on Thursday, November 10th. The stock was sold at an average price of $139.60, for a total value of $2,083,111.20. Following the completion of the transaction, the chief executive officer now directly owns 12,310 shares in the company, valued at approximately $1,718,476. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 69,209 shares of company stock valued at $9,708,325. Corporate insiders own 0.26% of the company’s stock.

About Procter & Gamble

(Get Rating)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGGet Rating).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.